3
With successful Mizoroki-Heck conditions to prepare 12 in
hand, the synthesis of denigrin A was accomplished (Scheme 2).
Lactam 14 was obtained in 93% yield by heating a mixture of
compound 12 with 4-methoxyphenethylamine 13 in refluxing
acetic acid for 6 h. It is worth noting that a lower yield (40%)
was observed in basic conditions using Hünig’s base.14a Finally,
removal of the methyl groups of 14 using boron tribromide
mixtures of E/Z. Fortunately, the vinylogous aldol
condensation18 of 8 with 4-methoxybenzaldehyde 15 using
sodium carbonate in MeOH furnished the desired Z-isomer 7 as a
sole product, in 89 % yield. Next step was the lactamization of
lactone 7, which was our last key reaction.19 We expected that the
desired geometry would be attainable due to the comparatively
hindered nature of the furanone moiety. Thus, compound 7 was
treated with 4-methoxyphenethylamine 13 in dichloromethane at
room temperature for 40 h. The reaction mixture containing
intermediate 16 was then heated in refluxing acetic acid for 4 h to
produce the desired benzylidene-diarylpyrrol-2(5H)-one 6Z as a
major product (6Z : 6E = 8 : 1, separable by silica gel column
chromatography) in 74% yield in one-pot fashion. It was
necessary to use 5 equivalents of amine 13 in order to drive the
reaction to completion. Finally, methyl ether cleavage of 6 with
boron tribromide smoothly led to denigrin B (2) in 89% yield
1
provided denigrin A (1) in 97% yield (62% overall). The H and
13C NMR spectra of synthetic specimen were fully identical to
those reported previously.5
(31% overall) whose H and 13C NMR spectra were in excellent
1
agreement with those reported in the literature.5
Scheme 2. Synthesis of denigrin A.
In conclusion, the first total syntheses of denigrins A and B,
marine antitubercular pyrrole alkaloids, were accomplished in 3
and 5 steps in 62 and 31% overall yields, respectively from
commercially available maleic anhydride. This synthetic route is
reproducible, relies on inexpensive reagents, and demonstrates
the remarkable performance of maleic anhydride in Mizoroki-
Heck coupling using a diaryliodonium salt. Structure-activity-
relationship studies of denigrins enabled by this established
synthetic route are currently underway in our laboratory.
Subsequently, our attention was directed to the synthesis of
denigrin B (Scheme 3). Treatment of 12 with LiAlH4 facilitated
the selective reduction of a carbonyl group17 to afford 3,4-
diarylbutenolide 8 in 86% yield. Our first task in this synthesis
was the vinylogous aldol condensation to prepare 7. Generally,
vinylogous aldol condensations of butenolides having a bulky
C4-substituent, such as Ar, i-Pr, or Br, tend to lead to Z-products,
whereas those bearing a small substituent such as Me, provide
Scheme 3. Total synthesis of denigrin B. Ar = p-OMe-C6H4
5. Murali Krishna Kumar M, Devilal Naik J, Satyavathi K, Ramana
H, Raghuveer Varma P, Purna Nagasree K, Smitha D, Venkata Rao
D. Nat. Prod. Res. 2014; 28: 888.
6. El Sayed KA, Hamann MT, Abd El-Rahman HA, Zaghloul AM. J.
Nat. Prod. 1998; 61: 848.
Acknowledgments
M.K. thanks to the Takeda Science Foundation for a
postdoctoral research fellowship.
7. Cain CC, Lee D, Waldo Iii RH, Henry AT, Casida EJ, Wani MC,
Wall ME, Oberlies NH, Falkinham Iii JO. Antimicrob. Agents
Chemother. 2003; 47: 2113.
Supplementary Material
8. Pullen C, Schmitz P, Meurer K, v. Bamberg D, Lohmann S, De
Castro França S, Groth I, Schlegel B, Möllmann U, Gollmick F,
Gräfe U, Leistner E. Planta 2002; 216: 162.
9. Mishra SK, Tripathi G, Kishore N, Singh RK, Singh A, Tiwari
VK. Eur. J. Med. Chem. 2017; 137: 504.
Supplementary data (detailed experimental procedures,
compounds characterization data, and copies of 1H and 13C NMR
spectra for all new compounds) associated with this article can be
found, in the online version.
10. Rudi A, Goldberg I, Stein Z, Frolow F, Benayahu Y, Schleyer M,
Kashman Y. J. Org. Chem. 1994; 59: 999.
References and notes
11. Warabi K, Matsunaga S, van Soest RWM, Fusetani N. J. Org.
Chem. 2003; 68: 2765.
12. (a) Rudi A, Evan T, Aknin M, Kashman Y. J. Nat. Prod. 2000;
63: 832; (b) Chen X, Zheng Y, Shen Y. Chem. Rev. 2007; 107: 1777;
(c) Stewart SG, Polomska ME, Lim RW. Tetrahedron Lett. 2007; 48:
2241.
13. (a) Fields EK, Behrend SJ, Meyerson S, Winzenburg ML, Ortega
BR, Hall HK. J. Org. Chem. 1990; 55: 5165; (b) Dean WD, Blum
DM. J. Org. Chem. 1993; 58: 7916; (c) Beccalli EM, Gelmi ML,
1. World Health Organizati n. . Bending the curve - ending
TB: Annual report 2017. WHO Regional Office for South-East Asia.
2. van den Boogaard J, Kibiki GS, Kisanga ER, Boeree MJ,
Aarnoutse RE. Antimicrob. Agents Chemother. 2008; 53: 849.
3. de Souza MVN. Fitoterapia 2009; 80: 453.
4 (a) Kishore N, Mishra BB, Tripathi V, Tiwari VK. Fitoterapia
2009; 80: 149; (b) Gholap SS. Eur. J. Med. Chem. 2016; 110: 13.